Company: SNWV
Filing Date: 2025-07-10
Form Type: DEF 14A
Source: 0001140361-25-025486
Chunk: 42

Company: SANUWAVE Health, Inc.
Filing Date: 2025-07-10
Form: DEF 14A
Chunk 42
---
97,916.67 in cash, which is equal to five months of her annual base salary, payable in equal installments on our regular payroll schedule. Outstanding Equity Awards at 2024 Fiscal Year End The following table provides certain information concerning the outstanding equity awards for each NEO as of December 31, 2024:

| Name                                           |     |   Number of 
  securities 
  underlying 
 unexercised 
     options 
 exercisable |     |          Number of 
         securities 
 underlying options 
      unexercisable |     | Equity incentive 
 plan awards      
 number of        
 securities       
 underlying       
 unexercised      
 unearned options |     | Exercise 
    price 
      ($) |     | Expiration 
 Date       |
| Morgan Frank, Chief Executive Officer          |     |           — |     |            160,000 |     | —                |     |   $14.20 |     | 10/22/2034 |
|                                                |     |       1,559 |     |                  — |     | —                |     |   $22.76 |     | 12/31/2029 |
| Andrew Walko, President                        |     |           — |     |            106,667 |     | —                |     |   $14.20 |     | 10/22/2034 |
| Nanci Gilmore, former Chief Commercial Officer |     |           — |     |             74,667 |     | —                |     |   $14.20 |     | 10/22/2034 |

Policies and Practices Related to the Grant of Certain Equity Awards We have established processes to ensure that the timing of any stock option grants to executives is not influenced by material nonpublic information (“MNPI”), and that all grant decisions are made based on a predetermined schedule, taking into account factors like employee performance and market conditions, regardless of any upcoming announcements or events that could impact our stock price. The Compensation Committee carefully reviews any potential MNPI before granting optionsand will delay a grant if necessary to avoid any appearance of impropriety related to the timing of the award.

27

TABLE OF CONTENTS

EQUITY COMPENSATION PLAN INFORMATION Securities Authorized for Issuance Under Equity Compensation Plans The following table provides information as of December 31, 2024 about our equity compensation plans under which shares of our common stock have been authorized for issuance.

| Plan category                                              |     |        Number of 
 securities to be